Eton Pharmaceuticals (ETON) Change in Accured Expenses (2018 - 2025)
Eton Pharmaceuticals (ETON) posted Change in Accured Expenses of $426000.0 for Q4 2025, down 76.15% sequentially from $1.8 million in Q3 2025, and down 79.15% YoY from $2.0 million in Q4 2024.
Eton Pharmaceuticals (ETON) Change in Accured Expenses (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Change in Accured Expenses for 8 years, with the latest figure at $426000.0 in Q4 2025.
- Quarterly Change in Accured Expenses fell 79.15% year-over-year to $426000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 31.87% YoY) and the FY2025 annual result came in at $1.0 million, down 31.87% from the prior year.
- Change in Accured Expenses slipped to $426000.0 in Q4 2025 per ETON's latest filing, from $1.8 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.0 million in Q4 2024 and troughed at -$1.6 million in Q1 2024.
- A 5-year average of $326850.0 and a median of $397000.0 in 2021 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses jumped 4230.0% in 2023, then plunged 232.28% in 2024.
- Over 5 years, Change in Accured Expenses stood at $120000.0 in 2021, then slumped by 153.33% to -$64000.0 in 2022, then jumped by 2246.88% to $1.4 million in 2023, then soared by 48.69% to $2.0 million in 2024, then plunged by 79.15% to $426000.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $426000.0, $1.8 million, and $172000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 426,000.00 |
| Dec 31, 2025 | 426,000.00 |
| Sep 30, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 172,000.00 |
| Jun 30, 2025 | 172,000.00 |
| Mar 31, 2025 | -1.37 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 574,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | 506,000.00 |
| Jun 30, 2024 | 506,000.00 |
| Mar 31, 2024 | -1.64 Mn |
| Mar 31, 2024 | -1.64 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | -942,000.00 |
| Sep 30, 2023 | -942,000.00 |